Non organ based laboratory markers in systemic sclerosis
McHugh, N.J.; Distler, O.; Giacomelli, R.; Riemekasten, G.
Clinical and Experimental Rheumatology 21(3 Suppl 29: S32-S38
2003
ISSN/ISBN: 0392-856X PMID: 12889220 Document Number: 564180
Candidate markers for endothelial cell, lymphocyte and fibroblast function in systemic sclerosis have been reviewed. Autoantibody measurement and general inflammatory markers were considered the minimum requirements, with other markers needing further evaluation.
Document emailed within 1 workday
Related Documents
Sawicka, K.; Michalska-Jakubus, M.łg.; Kowal, M.łg.; Potembska, E.; Krasowska, D. 2017: Resistin: a possible biomarker of organ involvement in systemic sclerosis patients? Clinical and Experimental Rheumatology 35 Suppl 106(4): 144-150Ross, L.; Stevens, W.; Rabusa, C.; Wilson, M.; Ferdowsi, N.; Walker, J.; Sahhar, J.; Ngian, G.-S.; Zochling, J.; Roddy, J.; Tymms, K.; Major, G.; Strickland, G.; Proudman, S.M.; Nikpour, M. 2018: The role of inflammatory markers in assessment of disease activity in systemic sclerosis Clinical and Experimental Rheumatology 36 Suppl 113(4): 126-134
Uras, C.; Tabolli, S.; Giannantoni, P.; Rocco, G.; Abeni, D. 2014: The Italian version of the Systemic Sclerosis Questionnaire: a comparison of quality of life in patients with systemic sclerosis and with other connective tissue disorders Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 149(5): 539-548
Hongwei, W.; Xinyu, Z.; Guihong, L.; Xiliang, L.; Hui, L. 2010: Nonspecific Biochemical Changes under Different Health Statuses and a Quantitative Model Based on Biological Markers to Evaluate Systemic Function in Humans Clinical Laboratory 56(5-6): 223-225
Stepień, M.; Cendrowski, W. 1974: Form of systemic lupus erythematosus (lupoid sclerosis) resembling multiple sclerosis Neurologia i Neurochirurgia Polska 8(4): 607-609
Hergesell, O.; Andrassy, K.; Nawroth, P. 1996: Elevated levels of markers of endothelial cell damage and markers of activated coagulation in patients with systemic necrotizing vasculitis Thrombosis and Haemostasis 75(6): 892-898
Gawrysiak, W.; Skrypnik, K.; Suliburska, J.; Skrypnik, D.; Bogdański, Pł. 2017: Cardiac complications in rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis Przeglad Lekarski 74(4): 179-182
Obata, T.; Takahashi, H.; Nosho, K.; Ikeda, Y.; Tokuno, T.; Kawahito, Y.; Honda, S.; Makiguchi, Y.; Imai, K.; Ikeda, T. 1998: A case of systemic lupus erythematosus overlapping with progressive systemic sclerosis accompanied by deposition of AA amyloid in the stomach Ryumachi 38(6): 810-817
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Whicher, J.T.; Gilbert, A.M.; Westacott, C.; Hutton, C.; Dieppe, P.A. 1986: Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease Clinical and Experimental Immunology 65(1): 80-89
Fauchet, R.; Madigand, M.; Gueguen-Duchesne, M.Y.; Papin, J.; Sabouraud, O.; Genetet, B. 1984: Complement markers Bf and C4 in multiple sclerosis Revue Neurologique (Paris) 140(6-7): 422-425
See, J.S.; Shen, E.Y.; Chiu, N.C.; Ho, C.S.; Lee, Y.L.; Chen, M.R.; Tsai, J.D. 1999: Tuberous sclerosis with visceral organ involvement Acta Paediatrica Taiwanica 40(5): 305-308
Paradowska-Gorycka, A.; Wajda, A.; Stolarek, I.; Felis-Giemza, A.; Walczyk, M.; Nałecz-Janik, J.; Olesińska, M. 2019: Is the T-G-CT-G SNRNP70 haplotype another proof that mixed connective tissue disease is distinct from systemic lupus erythematosus and systemic sclerosis? a novel gene variant in SNRNP70 gene Clinical and Experimental Rheumatology 37 Suppl 119(4): 32-40
Watanabe, N. 1996: Organ specificity of tumor markers and its application for clinical diagnosis Nihon Rinsho. Japanese Journal of Clinical Medicine 54(6): 1592-1596
Iriarte, J.; de Castro, Pón. 2002: Fatigue is not associated with raised inflammatory markers in multiple sclerosis Neurology 58(7): 1134; Author Reply 1134-5
Sekiguchi, S.; Saionji, K. 1991: Organ transplantation and laboratory tests Rinsho Byori. Japanese Journal of Clinical Pathology 39(5): 467-469
Koshkina, D.E.; Skvortsov, A.A.; Protasov, V.N.; Narusov, O.Y.; Tereshchenko, S.N. 2015: The Role of Markers of Organ Damage in Patients with Chronic Heart Failure Kardiologiia 55(1): 70-76
Losy, J.; Michałowska-Wender, G. 2001: Surface CD2, CD4, CD8 markers and IL-2 and TNF-alpha cytokines in amyotrophic lateral sclerosis Neurologia i Neurochirurgia Polska 35(1): 57-61
Gustafsson, R. 1994: Systemic sclerosis Nordisk Medicin 109(8-9): 236-237
Richardson, C.; Emery, P. 1996: Laboratory markers of disease activity Journal of Rheumatology. Supplement 44: 23-30